The New York State Gaming Commission has made 11 disqualifications and one suspension in addition to purse redistributions of more than $100,000 and a number of fines over the past year due to the detected presence of the alkaloid glaucine in the urine and plasma of racehorses–mostly Standardbreds–it announced Thursday.
Glaucine, also known as Boldine Dimethyl Ether or 1,2,9,10-Tetramethoxyaporphin, has anti-inflammatory, antitussive, bronchodilatory and hallucinogenic properties that give it the potential to affect racehorse performance. Glaucine has not been approved for any use by the FDA and the Association of Racing Commissioners International (ARCI) does not reference it in its Uniform Classification Guidelines for Foreign Substances.
“New York is once again leading the way when it comes to preserving integrity in horse racing,” said Commission Executive Director Robert Williams. “The Commission took deliberative action based upon solid research to hold trainers accountable for substances found in horses under their care. We call on other jurisdictions around the country to follow suit to send a clear message: we will tolerate nothing short of fair and safe horse racing.”
For more information on the NYS Gaming Commission’s glaucine initiatives and findings and a link to a complete list of horses found to have had elevated levels of the substance, click here.